Clinical trials of human papillomavirus vaccines and beyond

Nat. Rev. Clin. Oncol. 10, 400–410 (2013); published online 4 June 2013; 10.1038/nrclinonc.2013.84 In the version of this Review article originally published online and in print in the July 2013 issue there were errors in the clinical data presented in Tables 2, 3 and 5. In addition, reference 68 should have been cited to support data in Table 2, and the efficacy of the bivalent vaccine in adenocarcinoma in situ was 76.